High Rates of Thromboembolic Events in Patients with Germ Cell Cancer Undergoing Cisplatin-Based Polychemotherapy

Publisher： Karger

E-ISSN： 1423-0399|96|4|399-405

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.96, Iss.4, 2016-04, pp. : 399-405

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Venous Thromboembolic Events in Germ Cell Cancer Patients Undergoing Platinum-Based Chemotherapy

By  

Oncology Research and Treatment, Vol. 36, Iss. 11, 2013-10 ,pp. : 663-668

Karger

Access to resources Recommend Favorite

Cisplatin-Based Chemotherapy for Testicular Germ Cell Tumors: Complication Rates of Peripheral versus Central Venous Administration

By  

Urologia Internationalis, Vol. 96, Iss. 2, 2016-0 ,pp. : 177-182

Karger

Access to resources Recommend Favorite

Neoadjuvant Platinum-Based Chemotherapy is an Independent Predictor for Preoperative Thromboembolic Events in Bladder Cancer Patients Undergoing Radical Cystectomy

By  

Current Urology, Vol. 10, Iss. 3, 2017-07 ,pp. : 132-135

Karger

Access to resources Recommend Favorite

Cisplatin-Based Chemotherapy for Pulmonary Metastasized Germ Cell Tumors of the Testis – Be Aware of Acute Respiratory Distress Syndrome

By  

Oncology Research and Treatment, Vol. 32, Iss. 3, 2009-02 ,pp. : 125-128

Karger

Access to resources Recommend Favorite

Sunitinib in Patients with Cisplatin-Refractory Germ Cell Tumors

By  

Oncology Research and Treatment, Vol. 35, Iss. 7-8, 2012-07 ,pp. : 455-456

Karger

Access to resources Recommend Favorite